All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

Provenge Gains Approval From Medicare Panel

March 31st 2011

The federal agency that determines Medicare reimbursements this week proposed to fully cover the cost of Provenge

FDA Panel Backs Experimental Brain Cancer Treatment

March 30th 2011

An FDA panel voted 7 to 3 (2 abstentions) in support of the NovoTTF-100A System

Drugmaker Prepares to Ship New Melanoma Drug

March 29th 2011

Bristol-Myers Squibb plans to start rolling out its newly approved melanoma drug ipilimumab (Yervoy) in the next several weeks

Follow Up Treatment With Tamoxifen

March 29th 2011

Tamoxifen, a common drug used to treat breast cancer, works by blocking the effect of estrogen on tumor cells.

Landmark Genome Analysis to Drive Multiple Myeloma Research

March 28th 2011

Genome sequencing may help researchers understand the pathogenesis of this cancer, which despite exhaustive research, is only partially understood

Ipilimumab Approved as Melanoma Treatment

March 25th 2011

The FDA has approved the novel drug ipilimumab for the treatment of patients with metastatic melanoma

New Melanoma Drug Applauded

March 25th 2011

Cancer researchers and patient advocates are hailing the FDA's approval of Yervoy (ipilimumab)

Mentholated Cigarettes No More Harmful Than Regular Cigarettes

March 24th 2011

Contrary to the conventional wisdom, mentholated cigarette smokers are less likely to develop lung cancer

Oncology Organizations Seek to Calm Public Amid Radiation Scare

March 23rd 2011

Nuclear crisis in Japan fuels public fears over radiation exposure

New Prostate Cancer Test Yields Promising Results

March 22nd 2011

A recent clinical study reviewed the surprising results of a new prostate cancer test.

NCCN 2011 Guidelines for Breast Cancer: Yes on Avastin, No on CYP2D6

March 21st 2011

As the Avastin (bevacizumab) drama continues at the FDA, the National Comprehensive Cancer Network (NCCN) has weighed in.

Dental Care Steps to Prevent and Treat Osteonecrosis of the Jaw

March 14th 2011

Everyone can benefit from good oral hygiene, but people with cancer need to pay particular attention to their dental health

Preoperative Therapy Offers Value to Patients

March 14th 2011

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response